Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $10.72 and traded as high as $10.84. Ono Pharmaceutical shares last traded at $10.84, with a volume of 1,326 shares traded.
Ono Pharmaceutical Price Performance
The company’s 50-day moving average price is $10.72 and its two-hundred day moving average price is $12.86. The company has a market capitalization of $5.57 billion, a P/E ratio of 8.09 and a beta of 0.59.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What is the Nikkei 225 index?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is a support level?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
